Lam Research Corporation (LRCX) Stock Forecast
Data as of Jul 31, 2026Technology · Current price $299.08 (+0.56%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 15, 2026 | Melissa Weathers | Deutsche Bank | $300.00 | +0.3% |
| Apr 9, 2026 | Mehdi Hosseini | Susquehanna | $350.00 | +17.0% |
| Mar 10, 2026 | Tom O'Malley | Barclays | $255.00 | -14.7% |
| Jan 29, 2026 | Timothy Arcuri | UBS | $275.00 | -8.1% |
| Jan 29, 2026 | Brian Chin | Stifel Nicolaus | $280.00 | -6.4% |
| Jan 29, 2026 | Mehdi Hosseini | Susquehanna | $325.00 | +8.7% |
| Jan 29, 2026 | Tom O'Malley | Barclays | $250.00 | -16.4% |
| Jan 21, 2026 | Melissa Weathers | Deutsche Bank | $260.00 | -13.1% |
| Jan 20, 2026 | Charles Shi | Needham | $250.00 | -16.4% |
| Jan 15, 2026 | Tom O'Malley | Barclays | $195.00 | -34.8% |
| Jan 12, 2026 | Mehdi Hosseini | Susquehanna | $250.00 | -16.4% |
| Dec 17, 2025 | Vijay Rakesh | Mizuho Securities | $200.00 | -33.1% |
| Dec 2, 2025 | Shane Brett | Morgan Stanley | $158.00 | -47.2% |
| Nov 25, 2025 | Timothy Arcuri | UBS | $175.00 | -41.5% |
| Oct 23, 2025 | Edward Yang | Oppenheimer | $200.00 | -33.1% |
| Oct 20, 2025 | Tom O'Malley | Barclays | $142.00 | -52.5% |
| Sep 22, 2025 | Shane Brett | Morgan Stanley | $125.00 | -58.2% |
| Sep 2, 2025 | Shane Brett | Morgan Stanley | $92.00 | -69.2% |
| Jul 31, 2025 | Joe Quatrochi | Wells Fargo | $98.00 | -67.2% |
| Jul 28, 2025 | Tom O'Malley | Barclays | $83.00 | -72.2% |
Top Analysts Covering LRCX
LRCX vs Sector & Market
| Metric | LRCX | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.13 | 2.36 | 2.42 |
| Analyst Count | 38 | 14 | 19 |
| Target Upside | +20.3% | +1710.9% | +18.0% |
| P/E Ratio | 56.43 | 37.61 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-29 | $27.53B | $30.15B | $32.62B | 23 |
| 2027-09-28 | $7.80B | $8.09B | $8.68B | 7 |
| 2027-09-29 | $7.93B | $8.39B | $8.90B | 6 |
| 2027-12-28 | $8.11B | $8.41B | $9.02B | 7 |
| 2027-12-29 | $8.23B | $8.71B | $9.24B | 6 |
| 2028-03-28 | $8.75B | $9.08B | $9.74B | 12 |
| 2028-03-29 | $8.87B | $9.38B | $9.95B | 5 |
| 2028-06-28 | $9.05B | $9.39B | $10.08B | 12 |
| 2028-06-29 | $9.25B | $9.79B | $10.38B | 5 |
| 2028-09-28 | $8.26B | $8.57B | $9.20B | 12 |
| 2028-09-29 | $8.26B | $8.75B | $9.28B | 5 |
| 2028-12-28 | $8.44B | $8.75B | $9.39B | 12 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-29 | $7.13 | $7.81 | $8.87 | 20 |
| 2027-09-28 | $2.05 | $2.15 | $2.36 | 7 |
| 2027-09-29 | $2.11 | $2.27 | $2.45 | 6 |
| 2027-12-28 | $2.16 | $2.26 | $2.48 | 11 |
| 2027-12-29 | $2.21 | $2.38 | $2.57 | 6 |
| 2028-03-28 | $2.34 | $2.46 | $2.69 | 8 |
| 2028-03-29 | $2.42 | $2.61 | $2.82 | 14 |
| 2028-06-28 | $2.45 | $2.57 | $2.81 | 8 |
| 2028-06-29 | $2.56 | $2.76 | $2.97 | 14 |
| 2028-09-28 | $2.15 | $2.25 | $2.46 | 8 |
| 2028-09-29 | $2.23 | $2.40 | $2.59 | 14 |
| 2028-12-28 | $2.17 | $2.28 | $2.50 | 12 |
Frequently Asked Questions
What is the analyst consensus for LRCX?
The consensus among 38 analysts covering Lam Research Corporation (LRCX) is Buy with an average price target of $342.28.
What is the highest price target for LRCX?
The highest price target for LRCX is $350.00, set by Mehdi Hosseini at Susquehanna on 2026-04-09.
What is the lowest price target for LRCX?
The lowest price target for LRCX is $40.00, set by Vijay Rakesh at Mizuho Securities on 2022-10-20.
How many analysts cover LRCX?
38 analysts have issued ratings for Lam Research Corporation in the past 12 months.
Is LRCX a buy or sell right now?
Based on 38 analyst ratings, LRCX has a consensus rating of Buy (2.13/5) with a +20.3% upside to the consensus target of $342.28.
What are the earnings estimates for LRCX?
Analysts estimate LRCX will report EPS of $7.81 for the period ending 2027-06-29, with revenue estimated at $30.15B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.